ArticleJournal of the International AIDS Society2015
Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.
Article in Journal of the International AIDS Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pleasure and PrEP: A Systematic Review of Studies Examining Pleasure, Sexual Satisfaction, and PrEP.Journal of sex research · 2022Pooled it
- Promoting positive condom use experiences among young black MSM: a randomized controlled trial of a brief, clinic-based intervention.Health education research · 2018Trial
- Methamphetamine use and HIV prevention: a qualitative study on challenges and opportunities for PrEP utilization.AIDS care · 2026Article
- Association of self-reported HIV infection with oral pre-exposure prophylaxis use among women of reproductive age in Lesotho: evidence from mixed-effects estimates of nationally representative data.Sexually transmitted infections · 2025Article
- Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016-2020.BioSocieties · 2025Article
- Prevent with Pleasure: A systematic review of HIV public communication campaigns incorporating a pleasure-based approach.PLOS global public health · 2025Article
- Decomposing Education-Based Inequalities in Pre-Exposure Prophylaxis Knowledge for HIV Prevention Among Women in Cote d'Ivoire.International journal of women's health · 2024Article
- Understanding Psychosocial Determinants of PrEP Uptake Among Cisgender Women Experiencing Heightened HIV Risk: Implications for Multi-Level Communication Intervention.Health communication · 2023Article
- From training wheels to chemical condoms: Exploring narratives of PrEP discontinuation.Health (London, England : 1997) · 2023Article
- Prescribing as affective clinical practice: Transformations in sexual health consultations through HIV pre-exposure prophylaxis.Sociology of health & illness · 2022Article
- Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe.BMC infectious diseases · 2022Article
- Living through and with the global HIV/AIDS pandemic: Distinct 'pandemic practices' and temporalities.Social science & medicine (1982) · 2022Article
- Crowdsourced PrEP Promotion Messages for an HIV High-Burden Area: A Framework-Based Content Analysis.AIDS education and prevention : official publication of the International Society for AIDS Education · 2022Article
- Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation.Social theory & health : STH · 2022Article
- Is mpox an STI? The societal aspects and healthcare implications of a key question.Wellcome open research · 2022Article
- Self-reported and pill count measures of adherence to oral HIV PrEP among female sex workers living in South-Western Uganda.PloS one · 2022Article
- Knowledgeable, aware / interested: Young black women's perceptions of pre-exposure prophylaxis.Frontiers in reproductive health · 2022Article
- An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.BMC public health · 2021Article
- Underlying factors related to HIV/AIDS prevention: investigating the willingness to take pre-exposure prophylaxis among men-who-have-sex-with-men in Germany.AIDS research and therapy · 2021Article
- Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.International journal of environmental research and public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Social scientists have much to contribute to the analysis of the real and potential contribution of pre-exposure prophylaxis (PrEP) to HIV prevention around the world. Beyond just a matter of clinical efficacy and getting pills into people's mouths, PrEP raises a number of important social-psychological questions that must be attended to in order to translate biomedical and clinical findings into uptake of PrEP among enough people at risk of HIV infection to produce population-level effectiveness. PrEP is a dynamic phenomenon with "dialectical" attributes that invite both optimism and cynicism as a desirable and effective HIV prevention strategy. PrEP disrupts traditional notions of "safe" and "unsafe" sex; it confers on its users a level of agency and control not generally achieved with condoms; and it affects sexual practices and sexual cultures in meaningful ways. As these dynamics play out in different contexts, and as new modes of PrEP administration emerge, it will be important for social scientists to be engaged in assessing their impact on PrEP implementation and effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.